Aim: Dental implant placement is potentially invasive and hemorrhagic. Patients on the new oral anticoagulants (NOAC) have a potential risk of hemorrhage postoperative. The present study systematically reviews if NOAC medication presents the potential to increase the bleeding risk after dental implant placement. Materials and methods: A systematic review was conducted of randomized clinical trials evaluating the risk of hemorrhage after dental implants in patients taking NOAC medication. The literature search was conducted using Cochrane Central Register of Controlled Trials, PubMed, Science Direct without the restriction of language from June 2010 to December 2018. The inclusion criteria were: anticoagulant therapy, dental implant placement and postoperative incidence of bleeding follow-up. The reviewers performed data extraction, bias risk assessment, and determination of the overall quality of evidence for each of the outcomes using the Jadad scale. Review results: Two articles regarding the incidence of bleeding risk post dental implant placement were included in the review. The first article showed that one patient from the intervention group and two patients from the control group presented slight bleeding the day after the surgery, with the relative risk of 0.919 and the 95% confidence interval of 0.078-10.844. The second article showed that two patients from the intervention group and two patients from the control group presented slight bleeding the day after the surgery, with the relative risk of 0.675 and the 95% confidence interval of 0.090-5.088. Conclusion:The results suggested that continuing the intake of NOAC during and post procedure has not increased the hemorrhage risk. Hence, drugs modification or alteration was not necessary. Clinical significance: More well-designed studies are required for future research.
Aim Antithrombotic medication represents a challenge for any dental practitioner due to the possible hemorrhage complications that can be associated with an important morbidity/mortality risk. The objective of the present literature review is to establish which dental procedures have a risk to increase the incidence of hemorrhage in patients on antithrombotic therapy. Materials and methods A systematic review of the literature was conducted using MEDLINE, PubMed, and DiscoverEd databases. The inclusion criteria used were as follows: Current antithrombotic therapy, invasive dental procedures, and postoperative incidence of bleeding follow-up. Results A total of 14 clinical studies and 5 literature reviews were selected after the initial screening. The incidence of hemorrhage was assessed for dental implant placements, dental extractions, simple dental procedures, and periodontal treatment. Conclusion A well-coagulated patient can safely have invasive dental procedures in a hospital environment or nonhospital setting without having their antithrombotic therapy altered. Local hemostatic measures can offer a proper hemorrhage control. How to cite this article Pirlog CD, Pirlog AM, Maghiar T. A Systematic Review of the Hemorrhage Risk for Patients on Antithrombotic Medication after Dental Procedures. World J Dent 2018;9(1):59-67.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.